JP Stock MarketDetailed Quotes

4570 Immuno-Biological Laboratories

Watchlist

538
+2+0.37%

20min DelayNot Open Jun 27 15:00 JST

5.01BMarket Cap-17299P/E (Static)

Immuno-Biological Laboratories Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(FY)Mar 31, 2022

(FY)Mar 31, 2021

(FY)Mar 31, 2020

(FY)Mar 31, 2019

Total revenue

-30.13%182.89M

188.33M

177.19M

22.71%794.62M

239.71M

261.74M

7.44%647.58M

4.52%602.75M

-26.18%576.69M

3.02%781.22M

Cost of revenue

1.12%71.62M

75.86M

74.39M

-1.10%267.91M

77.11M

70.83M

5.86%270.88M

-28.79%255.89M

11.97%359.36M

14.08%320.93M

Gross profit

-41.72%111.27M

112.47M

102.8M

39.82%526.71M

162.6M

190.92M

8.60%376.7M

59.59%346.86M

-52.78%217.34M

-3.50%460.29M

Operating expense

-1.99%115.13M

98.42M

102.22M

-6.13%468.33M

123.11M

117.47M

-15.13%498.91M

-27.67%587.83M

28.19%812.69M

20.58%633.97M

Staff costs

----

-10.25%177.36M

----

-0.42%197.63M

-7.91%198.46M

4.32%215.5M

-1.39%206.57M

Selling and administrative expenses

----

83.66%8.75M

----

-46.25%4.76M

-94.33%8.86M

115.71%156.14M

432.70%72.38M

-General and administrative expense

----

83.66%8.75M

----

-46.25%4.76M

-94.33%8.86M

115.71%156.14M

432.70%72.38M

Research and development costs

----

-4.73%179.66M

----

-29.40%188.59M

-16.10%267.11M

34.51%318.35M

36.78%236.67M

Other operating expenses

----

-4.97%102.57M

----

-4.82%107.94M

-7.58%113.41M

3.68%122.7M

-8.72%118.35M

Operating profit

-105.26%-3.87M

14.05M

577K

147.77%58.38M

39.49M

73.45M

49.28%-122.22M

59.52%-240.98M

-242.80%-595.35M

-256.00%-173.68M

Net non-operating interest income (expenses)

-461.54%-329K

-237K

-249K

283.77%283K

98K

91K

74.25%-154K

84.30%-598K

-8.58%-3.81M

11.05%-3.51M

Non-operating interest income

-109.42%-34K

--30K

--17K

178.44%1.36M

--365K

--361K

222.52%487K

75.58%151K

22.86%86K

-1.41%70K

Non-operating interest expense

9.26%295K

--267K

--266K

67.39%1.07M

--267K

--270K

-14.42%641K

-19.64%749K

-30.81%932K

-25.33%1.35M

Total other finance cost

----

32.80%2.96M

0.90%2.23M

Net investment income

42.75%-3.19M

2.36M

5.94M

51.71%4.56M

1.2M

-5.57M

-38.03%3.01M

526.47%4.85M

-123.66%-1.14M

449.27%4.81M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

-166K

-176.1M

-175M

Income from associates and other participating interests

-33.46%-203.84M

-107.29M

-6.2M

-67.94%-152.73M

-1.16%-90.94M

-89.9M

Special income (charges)

252.17%162K

6.18M

162.71%43.12M

39.1M

46K

1,496.60%16.41M

-94.41%1.03M

322.96%18.41M

-621.81%-8.26M

Less:Other special charges

-252.17%-162K

--0

---87K

-115.82%-50.62M

---45.8M

---46K

-1,946.60%-23.45M

93.85%-1.15M

---18.64M

----

Less:Write off

--0

---6.1M

6.53%7.5M

--6.7M

--0

5,866.95%7.04M

-50.21%118K

-97.13%237K

1,333.16%8.26M

Other non-operating income (expenses)

995.39%2.38M

946K

467K

-226.20%-7M

-8.66M

217K

-65.38%5.55M

22.17%16.02M

-21.19%13.11M

465.85%16.64M

Income before tax

-107.82%-4.85M

17.12M

12.75M

-12.18%-280.61M

-211.06M

62.03M

19.47%-250.14M

52.84%-310.63M

-301.64%-658.69M

-215.75%-164M

Income tax

-37.90%1.42M

1.43M

1.58M

5.73%9.12M

2.24M

2.29M

5.22%8.63M

-13.10%8.2M

184.38%9.43M

375.90%3.32M

Net income

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

-299.31%-668.13M

-217.87%-167.32M

Net income continuous operations

-110.50%-6.27M

--15.7M

--11.17M

-11.97%-289.73M

---213.3M

--59.74M

18.84%-258.77M

52.28%-318.83M

-299.31%-668.12M

-217.87%-167.32M

Noncontrolling interests

Net income attributable to the company

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

-299.31%-668.13M

-217.87%-167.32M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-110.50%-6.27M

15.7M

11.17M

-11.97%-289.73M

-213.3M

59.74M

18.84%-258.77M

52.28%-318.83M

-299.31%-668.13M

-217.87%-167.32M

Gross dividend payment

Basic earnings per share

-110.44%-0.67

1.69

1.19

-11.95%-31.1

-22.9

6.42

18.84%-27.78

54.96%-34.23

-283.45%-76

-182.74%-19.82

Diluted earnings per share

-110.50%-0.6735

1.6853

1.19

-11.95%-31.1

-22.9024

6.4142

18.84%-27.78

54.96%-34.23

-283.45%-76

-182.74%-19.82

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(FY)Mar 31, 2022	(FY)Mar 31, 2021	(FY)Mar 31, 2020	(FY)Mar 31, 2019
Total revenue	-30.13%182.89M	188.33M	177.19M	22.71%794.62M	239.71M	261.74M	7.44%647.58M	4.52%602.75M	-26.18%576.69M	3.02%781.22M
Cost of revenue	1.12%71.62M	75.86M	74.39M	-1.10%267.91M	77.11M	70.83M	5.86%270.88M	-28.79%255.89M	11.97%359.36M	14.08%320.93M
Gross profit	-41.72%111.27M	112.47M	102.8M	39.82%526.71M	162.6M	190.92M	8.60%376.7M	59.59%346.86M	-52.78%217.34M	-3.50%460.29M
Operating expense	-1.99%115.13M	98.42M	102.22M	-6.13%468.33M	123.11M	117.47M	-15.13%498.91M	-27.67%587.83M	28.19%812.69M	20.58%633.97M
Staff costs	----	----	----	-10.25%177.36M	----	----	-0.42%197.63M	-7.91%198.46M	4.32%215.5M	-1.39%206.57M
Selling and administrative expenses	----	----	----	83.66%8.75M	----	----	-46.25%4.76M	-94.33%8.86M	115.71%156.14M	432.70%72.38M
-General and administrative expense	----	----	----	83.66%8.75M	----	----	-46.25%4.76M	-94.33%8.86M	115.71%156.14M	432.70%72.38M
Research and development costs	----	----	----	-4.73%179.66M	----	----	-29.40%188.59M	-16.10%267.11M	34.51%318.35M	36.78%236.67M
Other operating expenses	----	----	----	-4.97%102.57M	----	----	-4.82%107.94M	-7.58%113.41M	3.68%122.7M	-8.72%118.35M
Operating profit	-105.26%-3.87M	14.05M	577K	147.77%58.38M	39.49M	73.45M	49.28%-122.22M	59.52%-240.98M	-242.80%-595.35M	-256.00%-173.68M
Net non-operating interest income (expenses)	-461.54%-329K	-237K	-249K	283.77%283K	98K	91K	74.25%-154K	84.30%-598K	-8.58%-3.81M	11.05%-3.51M
Non-operating interest income	-109.42%-34K	--30K	--17K	178.44%1.36M	--365K	--361K	222.52%487K	75.58%151K	22.86%86K	-1.41%70K
Non-operating interest expense	9.26%295K	--267K	--266K	67.39%1.07M	--267K	--270K	-14.42%641K	-19.64%749K	-30.81%932K	-25.33%1.35M
Total other finance cost	----	----	----	----	----	----	----	----	32.80%2.96M	0.90%2.23M
Net investment income	42.75%-3.19M	2.36M	5.94M	51.71%4.56M	1.2M	-5.57M	-38.03%3.01M	526.47%4.85M	-123.66%-1.14M	449.27%4.81M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets	0	0	-166K	-176.1M	-175M	0	0
Income from associates and other participating interests	0	0	0	-33.46%-203.84M	-107.29M	-6.2M	-67.94%-152.73M	-1.16%-90.94M	-89.9M
Special income (charges)	252.17%162K	0	6.18M	162.71%43.12M	39.1M	46K	1,496.60%16.41M	-94.41%1.03M	322.96%18.41M	-621.81%-8.26M
Less:Other special charges	-252.17%-162K	--0	---87K	-115.82%-50.62M	---45.8M	---46K	-1,946.60%-23.45M	93.85%-1.15M	---18.64M	----
Less:Write off	--0	--0	---6.1M	6.53%7.5M	--6.7M	--0	5,866.95%7.04M	-50.21%118K	-97.13%237K	1,333.16%8.26M
Other non-operating income (expenses)	995.39%2.38M	946K	467K	-226.20%-7M	-8.66M	217K	-65.38%5.55M	22.17%16.02M	-21.19%13.11M	465.85%16.64M
Income before tax	-107.82%-4.85M	17.12M	12.75M	-12.18%-280.61M	-211.06M	62.03M	19.47%-250.14M	52.84%-310.63M	-301.64%-658.69M	-215.75%-164M
Income tax	-37.90%1.42M	1.43M	1.58M	5.73%9.12M	2.24M	2.29M	5.22%8.63M	-13.10%8.2M	184.38%9.43M	375.90%3.32M
Net income	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M	-299.31%-668.13M	-217.87%-167.32M
Net income continuous operations	-110.50%-6.27M	--15.7M	--11.17M	-11.97%-289.73M	---213.3M	--59.74M	18.84%-258.77M	52.28%-318.83M	-299.31%-668.12M	-217.87%-167.32M
Noncontrolling interests
Net income attributable to the company	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M	-299.31%-668.13M	-217.87%-167.32M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-110.50%-6.27M	15.7M	11.17M	-11.97%-289.73M	-213.3M	59.74M	18.84%-258.77M	52.28%-318.83M	-299.31%-668.13M	-217.87%-167.32M
Gross dividend payment
Basic earnings per share	-110.44%-0.67	1.69	1.19	-11.95%-31.1	-22.9	6.42	18.84%-27.78	54.96%-34.23	-283.45%-76	-182.74%-19.82
Diluted earnings per share	-110.50%-0.6735	1.6853	1.19	-11.95%-31.1	-22.9024	6.4142	18.84%-27.78	54.96%-34.23	-283.45%-76	-182.74%-19.82
Dividend per share	0	0	0	0	0	0	0	0	0	0
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall